Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HCN1 | O60741 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | HCN4 | Q9Y3Q4 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3521719 | 0.89 | CTSD (0.43) | CTSDMAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL3620517 | 0.89 | CTSD (0.43) | CTSDMAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL3519120 | 0.87 | TP53 (0.43) | MAPTSMN1; SMN2NPC1RAB9ATP53 | |
| SCHEMBL3515943 | 0.86 | NPC1 (0.44) | CTSDMAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL3521802 | 0.85 | KMT2A (0.41) | CTSDMAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL3516277 | 0.84 | KMT2A (0.46) | MAPTSMN1; SMN2NPC1RAB9ATP53 | |
| SCHEMBL3516887 | 0.82 | CTSD (0.47) | CTSDMAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL13115467 | 0.80 | ELANE (0.33) | CTSDMAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL3615449 | 0.75 | KMT2A (0.44) | CTSDMAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL13135884 | 0.75 | MEN1 (0.42) | MAPTSMN1; SMN2NPC1RAB9ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8466238-B2 | Latent curing agents, epoxy resin compositions containing the same, sealing materials, and organic EL displays | MITSUI CHEMICALS, INC. (JP) | 2013-06-18 | — | — | US | disclosed |
| US-8466238-B2 | Latent curing agents, epoxy resin compositions containing the same, sealing materials, and organic EL displays | MITSUI CHEMICALS, INC. (JP) | 2013-06-18 | — | — | US | disclosed |
| US-20100253213-A1 | LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS | MITSUI CHEMICALS, INC (JP) | 2010-10-07 | — | — | US | disclosed |
| US-20100253213-A1 | LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS | MITSUI CHEMICALS, INC (JP) | 2010-10-07 | — | — | US | disclosed |
| EP-2199313-A1 | LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONATING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS | Mitsui Chemicals, Inc. (JP) | 2010-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100253213-A1 | LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS | LTA4H, EPHX2, EPHX1 | CTSD 3637/4885MAPT 1418/4885SMN1; SMN2 2719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.